Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Summit Therapeutics PLC (NASDAQ:SMMT)

12.68
Delayed Data
As of Jan 12
 +0.2501 / +2.01%
Today’s Change
8.80
Today|||52-Week Range
16.86
+14.44%
Year-to-Date
No recent news for Summit Therapeutics PLC.

Today’s Trading

Previous close12.43
Today’s open12.63
Day’s range12.57 - 12.90
Volume42,506
Average volume (3 months)39,513
Market cap$179.1M
Data as of 3:59pm ET, 01/12/2018

Growth & Valuation

Earnings growth (last year)-5.90%
Earnings growth (this year)+90.93%
Earnings growth (next 5 years)--
Revenue growth (last year)+166.82%
P/E ratioNM
Price/Sales46.76
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MLNTMelinta Therapeutics...-0.60-3.60%
ACRXAcelRx Pharmaceutica...0.000.00%
CDMOAvid Bioservices Inc+0.02+0.53%
RDHLRedhill Biopharma Lt...-0.03-0.58%
Data as of 4:15pm ET, 01/12/2018

Financials

Next reporting dateMarch 28, 2018
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$3.1M
Annual profit (last year)-$28.5M
Net profit margin-922.36%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Executive Director
Glyn O. Edwards
Chief Operating &
Medical Officer
David Roblin
Corporate headquarters
Abingdon, Oxfordshire

Forecasts